But Argus Research analyst Christine Dooley sees the dip as a buying opportunity. Dooley recently reiterated her buy rating ...

Fintel reports that on January 16, 2025, Argus Research upgraded their outlook for AT&T Inc. - Preferred Stock (NYSE:T.PRC) ...

Fintel reports that on January 16, 2025, Argus Research upgraded their outlook for AT&T Inc. - Preferred Stock (NYSE:T.PRA) ...

In a report released yesterday, Jasper Hellweg from Argus Research maintained a Buy rating on Novo Nordisk (NVO – Research Report). The ...

People with a “posh” English accent are seen as least likely to commit most crimes, with the exception of sex offences, new research ...

Chancellor, brings a revolutionary vision focused on community integration, curriculum transformation, and inclusive ...

Packaging Corp. of America is a manufacturer of containerboard and corrugated products. It is the third-largest producer of containerboard products and corrugated packaging, as well as a leading ...

Freeport-McMoRan is a leading international mining company based in Phoenix. It operates geographically diverse assets with significant proven and probable reserves of copper, gold, and molybdenum.

Argus Research analyst Stephen Biggar maintained a Buy rating on BlackRock (BLK – Research Report) yesterday. The company’s shares closed ...

NEW YORK, Jan. 16, 2025 /PRNewswire/ -- Argus Research, an independent investment research firm, has launched Equity Report coverage on Ambow Education Holding Ltd. (NYSEAM:AMBO). Click Here to view ...

A KEIGHLEY deli owner is taking part in clinical trials of a new drug which could transform bladder cancer treatment.

The Royal Marsden in London, where the Princess of Wales underwent treatment, is one of the world’s leading cancer hospitals.